Wael Saber

Medical College of Wisconsin — United States

Medicine · Health Sciences

58h-index13.8kcitations493works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(218), Acute Myeloid Leukemia Research(187), Acute Lymphoblastic Leukemia research(143), Chronic Myeloid Leukemia Treatments(97), Myeloproliferative Neoplasms: Diagnosis and Treatment(54)

Publications491 total

Validated clinical risk score for acute graft-versus-host disease in adult allogeneic hematopoietic cell transplantation
Blood Advances·2026Open Access
Outcomes of people living with acute lymphoblastic leukemia who received inotuzumab ozogamicin before a stem cell transplant: a plain language summary
Future Oncology·2025Open Access
Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia
Bone Marrow Transplantation·2025Open Access
CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study
Blood Advances·2025· 1 citedOpen Access
Superior long-term outcomes with fludarabine and melphalan reduced intensity regimen in older AML/MDS patients undergoing allogeneic stem cell transplantation: An analysis of CIBMTR data
Blood·2025Open Access
Real-world outcomes with blinatumomab as a bridging therapy for allogeneic hematopoietic stem cell transplantation in relapsed/refractory or measurable residual disease-positive B-cell acute lymphoblastic leukemia: A CIBMTR database analysis
Blood·2025
Post-transplant cyclophosphamide based GVHD prophylaxis in HLA-matched related and unrelated donor hematopoietic cell transplantation in adults with hematologic malignancies undergoing myeloablative conditioning: A CIBMTR analysis of 8,272 participants
Blood·2025Open Access
Acute Myeloid Leukemia (AML) with TP53 alteration and outcomes after allogeneic hematopoietic stem cell transplantation: A CIBMTR registry study
Blood·2025Open Access
Secondary graft failure after PT-cy: Modeling a candidate risk assignment biomarker based on lymphocyte reconstitution.  Results from the BMT CTN 1801 study.
Blood·2025Open Access
Combined TCR-seq and single-cell RNA-seq reveal distinct origins for antiviral immunity after post-transplant cyclophosphamide and tac/MTX gvhd prophylaxis: Results from the BMT CTN 1801 study
Blood·2025
The MEASURE Genome Atlas: Acute Myeloid Leukemia at diagnosis and complete remission
Blood·2025Open Access
Clinical, genetic, and pathologic differences across race, ethnicity, and sex in patients with MDS and precursor conditions from the national MDS natural history study
Blood·2025Open Access
Germline genetic variants and post-HCT cytokine/chemokine milieu may identify those at higher risk of primary graft failure after allogeneic hematopoietic cell transplantation, a blood and marrow transplant clinical trials network (BMT CTN) study
Blood·2025Open Access
Exposure to agent orange and risk of myelodysplastic syndromes
Blood·2025Open Access
Defining remission following hematopoietic cell transplant for myelofibrosis: an international expert panel consensus
Leukemia·2025Open Access
Germline Pathogenic Variants in <scp> <i>MUTYH</i> </scp> Are Associated With Inferior Survival After Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies or Disorders
American Journal of Hematology·2025Open Access
Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation
JCO Oncology Practice·2025Open Access
Corrigendum to: Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy – A Report from the CIBMTR, Transplantation and Cellular Therapy, 31:8, August 2025, 505-532; Article Number: JTCT-S-25-00377
Transplantation and Cellular Therapy·2025Open Access
Soluble urokinase plasminogen activator receptor and acute kidney injury in hematopoietic cell transplantation
Blood Advances·2025Open Access
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A <scp>CIBMTR</scp> study
British Journal of Haematology·2025· 1 cited
page 1 of 25Next →

Frequent Co-authors

Bipin N. Savani(21), Hillard M. Lazarus(17), Mahmoud Aljurf(17), David I. Marks(16), Rammurti T. Kamble(15), Baldeep Wirk(15), Robert Peter Gale(14), Taiga Nishihori(14), Daniel J. Weisdorf(12), Mark R. Litzow(12), Mary M. Horowitz(11), Stephen R. Spellman(11), Mehdi Hamadani(11), Stephanie J. Lee(10), Marcelo C. Pasquini(10), Richard F. Olsson(10), Parameswaran Hari(9), Kwang Woo Ahn(9), Edmund K. Waller(9), Richard T. Maziarz(8)